89bio, Inc. - Common stock, par value $0.001 per share (ETNB)
CUSIP: 282559103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 148,275,293
- Total 13F shares
- 154,687,811
- Share change
- -6,498,588
- Total reported value
- $2,273,679,348
- Put/Call ratio
- 838%
- Price per share
- $14.70
- Number of holders
- 197
- Value change
- -$595,162
- Number of buys
- 114
- Number of sells
- 103
Quarterly Holders Quick Answers
What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 282559103:
Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
3.6%
from 13D/G
|
20,788,363
|
$204,191,519 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
13%
|
19,889,683
|
$195,316,687 | — | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
14,210,000
|
$139,542,200 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.1%
|
10,569,424
|
$103,791,745 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
6.4%
|
9,500,000
|
$93,290,000 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
5.6%
|
8,242,154
|
$80,937,952 | $0 | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.6%
|
6,750,000
|
$66,285,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
4,249,957
|
$41,734,578 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.7%
|
4,035,390
|
$39,627,530 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
3,836,892
|
$37,678,279 | — | 30 Jun 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
2.3%
|
3,370,817
|
$33,101,423 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
3,111,299
|
$30,557,589 | — | 30 Jun 2025 | |
| Holocene Advisors, LP |
13F
|
Company |
2.1%
|
3,065,387
|
$30,102,100 | — | 30 Jun 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
3.6%
|
4,333,885
|
$29,903,806 | $0 | 31 Dec 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.7%
|
2,475,000
|
$24,304,500 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
2,274,151
|
$22,332,163 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.5%
|
2,185,005
|
$21,456,760 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
2,171,194
|
$21,321,125 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,829,436
|
$21,093,397 | — | 25 Jan 2022 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,037,087
|
$20,004,194 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
1,969,000
|
$19,335,580 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
13D/G
|
Company |
1.3%
from 13D/G
|
1,967,527
|
$19,321,115 | — | 30 Jun 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.2%
|
1,844,370
|
$18,111,713 | — | 30 Jun 2025 | |
| Redmile Group, LLC |
13F
|
Company |
1%
|
1,545,208
|
$15,173,943 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
1,253,085
|
$12,305,294 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
1,249,954
|
$12,274,549 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.82%
|
1,222,661
|
$12,006,531 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.8%
|
1,183,223
|
$11,619,681 | — | 30 Jun 2025 | |
| University of Wisconsin Foundation |
13F
|
Company |
0.78%
|
1,153,357
|
$11,325,966 | — | 30 Jun 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.77%
|
1,145,813
|
$11,251,884 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
1,132,437
|
$11,120,531 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
1,063,972
|
$10,448,205 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.71%
|
1,050,000
|
$10,311,000 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.65%
|
962,474
|
$9,451,495 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.61%
|
902,076
|
$8,858,386 | — | 30 Jun 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.6%
|
883,000
|
$8,675,180 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.59%
|
875,983
|
$8,602,153 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.52%
|
766,211
|
$7,524,513 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.43%
|
638,827
|
$6,273,281 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.39%
|
576,973
|
$5,665,875 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.39%
|
571,602
|
$5,613,132 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.38%
|
569,005
|
$5,587,630 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
513,400
|
$5,041,588 | — | 30 Jun 2025 | |
| INFINITUM ASSET MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
500,000
|
$4,910,000 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
488,711
|
$4,799,142 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.26%
|
391,410
|
$3,843,647 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.26%
|
383,188
|
$3,762,903 | — | 30 Jun 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
0.25%
|
376,804
|
$3,700,215 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.25%
|
367,267
|
$3,606,562 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
349,572
|
$3,432,797 | — | 30 Jun 2025 |
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q3 2025
As of 30 Sep 2025,
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
154,687,811 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Pentwater Capital Management LP, BlackRock, Inc., Deep Track Capital, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Avoro Capital Advisors LLC, GLAZER CAPITAL, LLC, and JANUS HENDERSON GROUP PLC.
This page lists
197
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
181
Q3 2025 holders
197
Holder diff
16
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.